Su Jin Koh (Su-Jin Koh, SuJin Koh)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 19

Top Venues

BMC medical ethics

Expert opinion on biological therapy

Cancers

Breast cancer (Tokyo, Japan)

Ulsan University Hospital

Catholic University of Korea (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ulsan University Hospital Jan 01 2013

South Korea

Associate Professor :: Division of Hematology and Oncology

Education History

Catholic University of Korea Sep 01 2007 - Feb 28 2011

South Korea

PHD

Catholic University of Korea School of Medicine Mar 01 2004 - Aug 30 2007

South Korea

MSC :: Internal Medicine

University of Ulsan College of Medicine Mar 01 1993 - Feb 28 1999

South Korea

BSC

Publications

Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy 24 (4) (2024)
Min-Ho Park, Jae Hong Seo, Jung Ho Park, Min-Ki Seong, Keon Uk Park, Min Kyoon Kim, Myung Chul Chang, Su Jin Koh, Moon Hee Lee, Seung Taek Lim, Young-Bum Yoo, So Yeon Oh, Sung Hyun Kim, Keum Young Ahn, Tae Hong Park, Hana Ju, Eric Hyungseok Baek, Sinhye Kim, Nahyun Kim, Eunkyung Lee, Tae Hyun Kim
Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study. Expert opinion on biological therapy (2024)
Hyeon-Su Im, Insook Lee, Shinmi Kim, Jong Soo Lee, Ju-Hee Kim, Jae Young Moon, Byung Kyu Park, Kyung Hee Lee, Myung Ah Lee, Sang-Hoon Han, Yoonki Hong, Hyeyeoung Kim, Jaekyung Cheon, Su Jin Koh
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study. BMC medical ethics 24 (1) (2023)
Hyeon-Su Im, Insook Lee, Shinmi Kim, Jong Soo Lee, Ju-Hee Kim, Jae Young Moon, Byung Kyu Park, Kyung Hee Lee, Myung Ah Lee, Sang-Hoon Han, Yoonki Hong, Hyeyeoung Kim, Jaekyung Cheon, Su Jin Koh
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study. BMC medical ethics 24 (1) (2023)
Hyeon-Su Im, Insook Lee, Shinmi Kim, Jong Soo Lee, Ju-Hee Kim, Jae Young Moon, Byung Kyu Park, Kyung Hee Lee, Myung Ah Lee, Sang-Hoon Han, Yoonki Hong, Hyeyeoung Kim, Jaekyung Cheon, Su Jin Koh
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study. BMC medical ethics 24 (1) (2023)
Cheolkyung Sin, Hyeyeoung Kim, Hyeon-Su Im, Minsu Ock, Su Jin Koh
Development and pilot study of "Smart Cancer Care": a platform for managing side effects of chemotherapy. BMC health services research 23 (1) (2023)
Hyeon-Su Im, Insook Lee, Shinmi Kim, Jong Soo Lee, Ju-Hee Kim, Jae Young Moon, Byung Kyu Park, Kyung Hee Lee, Myung Ah Lee, Sang-Hoon Han, Yoonki Hong, Hyeyeoung Kim, Jaekyung Cheon, Su Jin Koh
Experience and perspectives of end-of-life care discussion and physician orders for life-sustaining treatment of Korea (POLST-K): a cross-sectional study. BMC medical ethics 24 (1) (2023)
Jin Sook Kim, Il Sun Ko, Su Jin Koh
[The Development of a Tool for Assessment of Spiritual Distress in Cancer Patients]. Journal of Korean Academy of Nursing 52 (1) (2022)
So Yeon Oh, Kownoh Park, Su Jin Koh, Jung Hun Kang, Myung Hee Chang, Kyung Hee Lee
Survey of Opioid Risk Tool Among Cancer Patients Receiving Opioid Analgesics. Journal of Korean medical science 37 (23) (2022)
Sook-Kyoung Heo, Eui-Kyu Noh, Hye Jin Seo, Yoo Jin Lee, Su Jin Koh, Young Joo Min, Yunsuk Choi, Jae-Cheol Jo
Radotinib inhibits multiple myeloma cell proliferation via suppression of STAT3 signaling. PloS one 17 (5) (2022)
Jung-Yeon Choi, Ji Yeon Lee, Jaeyong Shin, Chang Oh Kim, Kwang Joon Kim, In Gyu Hwang, Yun-Gyoo Lee, Su Jin Koh, Soojung Hong, Sol-Ji Yoon, Min-Gu Kang, Jin Won Kim, Jee Hyun Kim, Kwang Ill Kim
COMPrehensive geriatric AsseSSment and multidisciplinary team intervention for hospitalised older adults (COMPASS): a protocol of pragmatic trials within a cohort. BMJ open 12 (8) (2022)
Shinmi Kim, Insook Lee, Sun-Woo Hong, Su Jin Koh
Psychometric properties of the end-of-life care decision inventory (EOL-CDI): a mixed-methods study. Health and quality of life outcomes 20 (1) (2022)
Su Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming-Shen Dai, Chuan-Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O'Shaughnessy, Judith Balmaña
Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast cancer (Tokyo, Japan) (2021)
Su Jin Koh, Shozo Ohsumi, Masato Takahashi, Eisuke Fukuma, Kyung Hae Jung, Takanori Ishida, Ming-Shen Dai, Chuan-Hsun Chang, Tapashi Dalvi, Graham Walker, James Bennett, Joyce O'Shaughnessy, Judith Balmaña
Correction to: Prevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study. Breast cancer (Tokyo, Japan) (2021)
In Gyu Hwang, Minsuk Kwon, Jin Won Kim, Se Hyun Kim, Yun-Gyoo Lee, Jin Young Kim, Su Jin Koh, Yoon Ho Ko, Seong Hoon Shin, Soojung Hong, Tae-Yong Kim, Sun Young Kim, Hyun Jung Kim, Hyo Jung Kim, Myung Ah Lee, Jung Hye Kwon, Yong Sang Hong, Kyung Hee Lee, Sung Hwa Bae, Dong-Hoe Koo, Jee Hyun Kim, In Sook Woo
Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study. Cancers 13 (2) (2021)
Jaekyung Cheon, Yunsuk Choi, Jin Sung Kim, Byung Kyun Ko, Chung Reen Kim, Ju Hee Kim, Su Jin Koh
"Teachable Moment": Effects of an Educational Program on Knowledge and Quality of Life of Korean Breast Cancer Survivors. Journal of cancer education : the official journal of the American Association for Cancer Education (2020)
Soohyeon Lee, Seock-Ah Im, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee-Jun Kim, Han Jo Kim, Jong-In Lee, Su Jin Koh, Yeon Hee Park
Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10). Cancers 12 (11) (2020)

Su Jin Koh.css-eqlu8i{font-size:small;padding-left:4px;} (Su-Jin Koh, SuJin Koh)

Publication Activity (10 Years)

Top Topics

Top Venues

Su Jin Koh (Su-Jin Koh, SuJin Koh)